Table of Contents

2019-2024 Global Contraceptives Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Contraceptives Consumption 2014-2024
  • 2.1.2 Contraceptives Consumption CAGR by Region
• 2.2 Contraceptives Segment by Type
  • 2.2.1 Prolonged Contraception
  • 2.2.2 Short-term Contraception
  • 2.2.3 Emergency Contraception
• 2.3 Contraceptives Consumption by Type
  • 2.3.1 Global Contraceptives Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Contraceptives Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Contraceptives Sale Price by Type (2014-2019)
• 2.4 Contraceptives Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Pharmacies
  • 2.4.4 Others
• 2.5 Contraceptives Consumption by Application
  • 2.5.1 Global Contraceptives Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Contraceptives Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Contraceptives Sale Price by Application (2014-2019)

3 Global Contraceptives by Players

• 3.1 Global Contraceptives Sales Market Share by Players
  • 3.1.1 Global Contraceptives Sales by Players (2017-2019)
  • 3.1.2 Global Contraceptives Sales Market Share by Players (2017-2019)
• 3.2 Global Contraceptives Revenue Market Share by Players
  • 3.2.1 Global Contraceptives Revenue by Players (2017-2019)
  • 3.2.2 Global Contraceptives Revenue Market Share by Players (2017-2019)
• 3.3 Global Contraceptives Sale Price by Players
• 3.4 Global Contraceptives Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Contraceptives Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Contraceptives Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Contraceptives by Regions

• 4.1 Contraceptives by Regions
  • 4.1.1 Global Contraceptives Consumption by Regions
  • 4.1.2 Global Contraceptives Value by Regions
• 4.2 Americas Contraceptives Consumption Growth
• 4.3 APAC Contraceptives Consumption Growth
• 4.4 Europe Contraceptives Consumption Growth
• 4.5 Middle East & Africa Contraceptives Consumption Growth

5 Americas

• 5.1 Americas Contraceptives Consumption by Countries
  • 5.1.1 Americas Contraceptives Consumption by Countries (2014-2019)
  • 5.1.2 Americas Contraceptives Value by Countries (2014-2019)
• 5.2 Americas Contraceptives Consumption by Type
• 5.3 Americas Contraceptives Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Contraceptives Consumption by Countries
  • 6.1.1 APAC Contraceptives Consumption by Countries (2014-2019)
  • 6.1.2 APAC Contraceptives Value by Countries (2014-2019)
• 6.2 APAC Contraceptives Consumption by Type
• 6.3 APAC Contraceptives Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Contraceptives by Countries
  • 7.1.1 Europe Contraceptives Consumption by Countries (2014-2019)
  • 7.1.2 Europe Contraceptives Value by Countries (2014-2019)
• 7.2 Europe Contraceptives Consumption by Type
• 7.3 Europe Contraceptives Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Contraceptives by Countries
  • 8.1.1 Middle East & Africa Contraceptives Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Contraceptives Value by Countries (2014-2019)
• 8.2 Middle East & Africa Contraceptives Consumption by Type
• 8.3 Middle East & Africa Contraceptives Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Contraceptives Distributors
• 10.3 Contraceptives Customer

11 Global Contraceptives Market Forecast

• 11.1 Global Contraceptives Consumption Forecast (2019-2024)
• 11.2 Global Contraceptives Forecast by Regions
  • 11.2.1 Global Contraceptives Forecast by Regions (2019-2024)
  • 11.2.2 Global Contraceptives Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Contraceptives Forecast by Type
• 11.8 Global Contraceptives Forecast by Application

12 Key Players Analysis

• 12.1 Bayer AG
  • 12.1.1 Company Details
  • 12.1.2 Contraceptives Product Offered
  • 12.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer AG News
• 12.2 Pfizer, Inc
  • 12.2.1 Company Details
  • 12.2.2 Contraceptives Product Offered
  • 12.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer, Inc News
• 12.3 Teva Pharmaceutical Industries Ltd
  • 12.3.1 Company Details
  • 12.3.2 Contraceptives Product Offered
  • 12.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva Pharmaceutical Industries Ltd News
• 12.4 Merck & Co., Inc
  • 12.4.1 Company Details
  • 12.4.2 Contraceptives Product Offered
  • 12.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Merck & Co., Inc News
• 12.5 Actavis, Inc.
  • 12.5.1 Company Details
  • 12.5.2 Contraceptives Product Offered
  • 12.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Actavis, Inc. News
• 12.6 Johnson & Johnson
  • 12.6.1 Company Details
  • 12.6.2 Contraceptives Product Offered
  • 12.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Johnson & Johnson News
• 12.7 Gedeon Richter
  • 12.7.1 Company Details
  • 12.7.2 Contraceptives Product Offered
  • 12.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Gedeon Richter News
• 12.8 Novo Nordisk A/S
  • 12.8.1 Company Details
  • 12.8.2 Contraceptives Product Offered
  • 12.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Novo Nordisk A/S News
• 12.9 ZiZhu
  • 12.9.1 Company Details
  • 12.9.2 Contraceptives Product Offered
  • 12.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 ZiZhu News
• 12.10 Baijingyu
  • 12.10.1 Company Details
  • 12.10.2 Contraceptives Product Offered
  • 12.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Baijingyu News
• 12.11 Huazhong
• 12.12 Sine

13 Research Findings and Conclusion

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
In the next five years, the global consumption of Contraceptives will maintain more than 2% annual growth rate, Industry is mainly concentrated in Europe, USA, Japan and China.
At present, Chinese domestic enterprise technology is developing fast, and these companies mainly supply the local market.
Short-acting contraceptive occupied the largest market share of the contraceptives market, and the Long-acting contraceptive is the second.

According to this study, over the next five years the Contraceptives market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contraceptives business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives market by product type, application, key manufacturers and key regions and countries.

This study considers the Contraceptives value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Prolonged Contraception
Short-term Contraception
Emergency Contraception
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Contraceptives consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Contraceptives market by identifying its various subsegments.
Focuses on the key global Contraceptives manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Contraceptives with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Contraceptives submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.